Page 821 - 先天性心脏病的导管术：从婴幼儿期到成人期

64 先天性心导管实验室的质量改进工具和风险降低 803

影响力的进步，但仍需要做更多的工作来确保提供最佳的护理服务，并在不牺牲程序
效率的情况下继续关注以患者为中心的结果。

参考文献

[1] Langley GJ, Moen RD, Nolan KM, Nolan TW, Norman CL, Provost LP. In: Langley

GJ, editor. The improvement guide a practical approach to enhancing organizational
performance. 2nd ed. San Francisco: Jossey-Bass; 2009.
[2] Institute for Healthcare Improvement: Open School. IHI Open School: The science of
improvement on a whiteboard! Institute for Healthcare Improvement Open School;

2019.
[3] Moore JW, Vincent RN, Beekman RH III, et al. Procedural results and safety of com-
mon interventional procedures in congenital heart disease: initial report from the Na-
tional Cardiovascular Data Registry. J Am Coll Cardiol. 2014;64(23):2439.51. https://

doi.org/10.1016/j.jacc.2014.09.045.
[4] Cevallos PC, Rose MJ, Armsby LB, et al. Implementation of methodology for quality
improvement in pediatric cardiac catheterization: a multicenter initiative by the congeni-
tal cardiac catheterization project on outcomes-quality improvement (C3PO-QI). Pediatr

Cardiol. 2016;37(8):1436-45. https://doi.org/10.1007/s00246-016-1454-z.
[5] Martin GR, Anderson JB, Vincent RN. IMPACT Registry and National Pediatric Car-
diology Quality Improvement Collaborative: Contributions to Quality in Congenital
Heart Disease. World J Pediatr Congenit Heart Surg. 2019;10(1):72-80. https://doi.

org/10.1177/2150135118815059.
[6] Nykanen DG, Forbes TJ, Du W, et al. CRISP: catheterization risk score for pediatrics: a
report from the Congenital Cardiac Interventional Study Consortium (CCISC). Catheter
Cardiovasc Interv. 2016;87(2):3029. https://doi.org/10.1002/ccd.26300.

[7] Quinn BP, Armstrong AK, Bauser-Heaton HD, et al. Radiation risk categories in cardiac
catheterization for congenital heart disease: a tool to aid in the evaluation of radiation
outcomes. Pediatr Cardiol. 2019;40(2):445-53. https://doi.org/10.1007/s00246-018-
2024-3.

[8] Ghelani SJ, Glatz AC, David S, et al. Radiation dose benchmarks during cardiac cath-
eterization for congenital heart disease in the United States. JACC Cardiovasc Interv.